Search Results

Biotech Bay

Credence MedSystems Announces a Significant Milestone Towards Scaling Manufacturing Capabilities

Credence MedSystems announced that it has successfully completed Factory Acceptance Testing for production of its Companion® injection device platform on the Company’s new Clinical Assembly Line.

January 18, 2024

·

3 min read

Deals

Boston Scientific Closes Acquisition of Relievant Medsystems, Inc.

Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Relievant Medsystems Inc.

November 17, 2023

·

5 min read

Business

Credence MedSystems Announces Strategic Collaboration With Phillips-Medisize

Credence MedSystems, Inc. announced today that it has formed a strategic collaboration with Phillips-Medisize, a Molex company, a global leader in the design and manufacturing of solutions for the pharmaceutical drug delivery market.

October 19, 2021

·

4 min read

Deals

Boston Scientific Announces Agreement to Acquire Relievant Medsystems, Inc.

Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire Relievant Medsystems, Inc., a privately held medical technology company.

September 19, 2023

·

6 min read

Biotech Bay

Credence MedSystems Secures $39.9 Million Financing to Enable Scaling of Innovative Drug Delivery and Connected Health Systems

Credence MedSystems, Inc. announced today that it has closed a funding round with gross proceeds of $39.9 million. Sources of funding include strategic investments from Novartis Pharma AG, Molex Ventures LLC as well as additional investors.

September 22, 2021

·

2 min read

BioMidwest

Relievant Medsystems Announces Positive Coverage Policy for the Intracept Procedure from Anthem Blue Cross and Blue Shield

Relievant Medsystems, a company dedicated to transforming the diagnosis and treatment of vertebrogenic low back pain, announced that Anthem Blue Cross and Blue Shield has established favorable coverage for the Intracept® Procedure.

October 3, 2023

·

3 min read

Relievant Medsystems Introduces Next-Generation Access Instruments to Advance Intracept Procedure for Chronic Vertebrogenic Low Back Pain

Relievant Medsystems today announced the release of next-generation Intracept ® Access Instruments.

July 14, 2023

·

3 min read

BioMidwest

Relievant Medsystems Announces Pooled Analysis Demonstrating the Intracept Procedure Significantly Reduces Low Back Pain-related Healthcare Utilization

Relievant Medsystems announced the publication of a pooled analysis from three prospective clinical trials that demonstrates the impact of the company’s Intracept® Procedure on significantly reducing the long-term utilization of additional treatments for low back pain.

September 12, 2023

·

4 min read

BioMidwest

Relievant Medsystems Announces Pooled 4-Year Outcomes Validating Long-Term Effectiveness of the Intracept Procedure

Relievant Medsystems announced the presentation of four-year pooled results from two prospective clinical trials that further demonstrate the safety, effectiveness and long-term durability of the Intracept® Procedure for patients with vertebrogenic pain.

July 20, 2023

·

3 min read

Biotech Bay

Avail Medsystems Announces Participation Throughout the Society of Robotic Surgery (SRS) Annual Meeting

Avail Medsystems, the digital hub of the operating room (OR) enabling the MedTech and healthcare industries to work smarter together to advance patient care, today announced it will participate as a platinum partner in the Society of Robotic Surgery (SRS) Annual Meeting to be held July 24-26, 2023 in Melbourne, Australia.

July 20, 2023

·

3 min read